Protective effects of Celsior in lung transplantation

Journal of Heart and Lung Transplantation

Volumn 18, Issue 4, 1999, Pages 320-327

  Xiong, Lihua ^a   Legagneux, Josette ^a   Wassef, Michel ^a   Oubenaïssa, Abdeslam ^a   Détruit, Hélène ^a   Mouas, Christian ^a   Menasché, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELSIOR; PRESERVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FUNCTIONAL ASSESSMENT; GRAFT REJECTION; GRAFT SURVIVAL; LUNG TRANSPLANTATION; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; RAT;

EID: 0032914798     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(98)00032-1     Document Type: Article

References (26)

1. Menasché P., Termignon J.L., Pradier F., et al. Experimental evaluation of Celsior®, a new heart preservation solution. Eur J Cardio-thorac Surg. 8:1994;207-213.
2. Menasché P. Clinical studies of Celsior, a new heart preservation solution. J Heart Lung Transplant. 16:1997;60. (abstract).
3. Reignier J., Mazmanian M., Chapelier A., et al. Evaluation of a new preservation solution Celsior in the isolated rat lung . J Heart Lung Transplant. 14:1995;601-604.
4. Barr M.L., Nishanian G.P., Sakamaki Y., Carey J.N., Chang J., Starnes V.A. A new organ preservation solution, Celsior, is superior to Euro-Collins and University of Wisconsin solutions in decreasing lung reperfusion injury. Transplant Proc. 29:1997;1357-1358.
5. Marck K.W., Vildevuur C.R.H. Lung transplantation in the rat: I. technique and survival. Ann Thorac Surg. 34:1982;74-80.
6. Hausen B., Mueller P., Bahra M., Ramsamooj R., Morris R.E., Hewitt C.W. Donor treatment with the lazeroid U74389G reduces ischemia-reperfusion injury in a rat lung transplant model. Ann Thorac Surg. 64:1997;814-820.
7. Mullane K.M., Kraemer R., Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration in ischemic myocardium. J Pharmacol Methods. 14:1985;157-167.
8. Xiong L., Mazmanian M., Chapelier A.R., et al. Lung preservation with Euro-Collins, University of Wisconsin, Wallwork, and low-potassium-dextran solutions. Ann Thorac Surg. 58:1994;845-850.
9. Binns O.A.R., De Lima N.F., Buchanan S.A., et al. Both blood and crystalloid-based extracellular solutions are superior to intracellular solutions for lung preservation. J Thorac Cardiovasc Surg. 112:1996;1515-1521.
10. Oka T., Puskas J.D., Mayer E., et al. Low-potassium UW solution for lung preservation. Comparison with regular UW, LPD and Euro-Collins solutions. Transplantation. 52:1991;984-988.
11. Miyoshi S., Shimokawa S., Schreinemakers H., et al. Comparison of the University of Wisconsin preservation solution and other crystalloid perfusates in a 30-hour rabbit lung preservation model. J Thorac Cardiovasc Surg. 103:1992;27-32.
12. Sasaki S., McCully J.D., Alessandrini F., LoCicero J. III. Impact of initial flush potassium concentration on the adequacy of lung preservation. J Thorac Cardiovasc Surg. 109:1995;1090-1096.
13. Belzer F.O., Southard J.H. Principles of solid-organ preservation by cold storage. Transplantation. 45:1988;673-676.
14. Rahn H., Reeves R.B., Howell B.J. Hydrogen ion regulation, temperature and evolution. Am Rev Resp Dis. 112:1975;165-172.
15. Hiramatsu Y., Muraoka M., Chiba Y., Sasaki M. Influence of pH of preservation solution on lung viability. Ann Thorac Surg. 58:1994;1083-1086.
16. Corcoran P.C., Tse S.S., Katz N.M., et al. Reduction of conjugated dienes in lung transplantation effect of BN 52021 . Ann Thorac Surg. 56:1993;1279-1284.
17. Seibert A.F., Haynes J., Taylor A. Ischemia-reperfusion injury in the isolated rat lung. Role of flow and endogenous leukocytes. Am Rev Respir Dis. 147:1993;270-275.
18. Zhai X., Ashraf M. Direct detection and quantification of singlet oxygen during ischemia and reperfusion in rat hearts. Am J Physiol. 269:1995;H1229-H1236.
19. Ferreira R., Burgos M., Llesuy S., et al. Reduction of reperfusion injury with mannitol cardioplegia. Ann Thorac Surg. 48:1989;77-84.
20. Charloux C., Ishii K., Paul M., Loisance D., Astier A. Reduced production of the deleterious hydroxyl free radical during the final reperfusion of isolated rabbit heart with the use of an improved sodium lactobionate-based cardioplegic medium. J Heart Lung Transplant. 13:1994;481-488.
21. Piétri S., Culcasi M., Albat B., Albérici G., Menasché P. Direct assessment of the antioxidant effects of a new heart preservation solution, Celsior. A hemodynamic and electron spin resonance study. Transplantation. 58:1994;739-742.
22. King R.C., Binns O.A.R., Kanithanon R.C., et al. Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia. Ann Thorac Surg. 64:1997;795-800.
23. Schueler S., De Valeria P.A., Hatanaka M., et al. Successful twenty-four-hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model. J Thorac Cardiovasc Surg. 104:1992;73-82.
24. Bhabra M.S., Hopkinson D.N., Shaw T.E., Onwu M., Hooper T.L. Controlled reperfusion protects lung grafts during a transient early increase in permeability. Ann Thorac Surg. 65:1998;187-192.
25. Kirk A.J.B., Colquhoun I.W., Dark J.H. Lung preservation a review of current practice and future directions . Ann Thorac Surg. 56:1993;990-1000.
26. Aeba R., Keenan R.J., Hardesty R.L., Yousem S., Hamamoto I., Griffith B.P. University of Wisconsin solution for pulmonary preservation in a rat transplant model. Ann Thorac Surg. 53:1992;240-246.